Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions
Clinical trial NCT01467687 · COMPLETED
Trial details
- NCT number
- NCT01467687
- Sponsor
- Synerx Pharma, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2007-08-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.